
Motiwin 1mg/ml Suspension
Marketer
Maneesh Pharmaceuticals Ltd
Salt Composition
Domperidone (1mg/ml)
Overview Motiwin 1mg/ml Suspension
PediaGast 1mg/ml oral suspension offers relief from indigestion, gastroesophageal reflux, nausea, and vomiting in pediatric patients. It accelerates gastric emptying and intestinal transit, easing bloating, satiety, and stomach upset. Administer PediaGast 1mg/ml 30 minutes prior to meals for optimal absorption. Post-meal administration remains effective, though absorption might be reduced. Infants may receive a doctor-prescribed four times daily regimen, spaced at least four hours apart, ideally before each feeding. Dosage is individualized based on age, weight, and the child's specific condition. Never extend treatment beyond the prescribed period without consulting the physician. If vomiting occurs within 30 minutes, repeat the dose after the child is settled; avoid doubling the dose if it's nearing the next scheduled time. Mild, transient side effects like dry mouth, headache, drowsiness, abdominal cramps, and diarrhea may occur, typically resolving as the child adjusts to the medication. Persistent or troublesome side effects warrant immediate medical attention. Inform your child's doctor of any prior allergies, cardiac issues, hematological disorders, congenital defects, respiratory obstructions, pulmonary abnormalities, gastrointestinal conditions, dermatological problems, hepatic impairment, or renal dysfunction. A complete medical history enables the physician to optimize dosage and treatment strategy.
Uses of Motiwin 1mg/ml Suspension
Managing gastroesophageal reflux disease (GERD), indigestion, nausea, and vomiting.
Major Benefits of Motiwin 1mg/ml Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Always consult the product label for detailed instructions prior to consumption. Use a measuring device for accurate administration and ingest orally. Ensure thorough shaking before each use. Motiwin 1mg/ml Suspension should be consumed on an empty stomach.
Common Side effects of Motiwin 1mg/ml Suspension:
- Dryness in mouth
- Headache
- Drowsiness
- Stomach cramp
- Diarrhea
How to use Motiwin 1mg/ml Suspension:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Always consult the product label for usage instructions prior to consumption. Use a measuring device to accurately dispense the oral dose. Ensure thorough shaking before each use. Motiwin 1mg/ml Suspension should be ingested on an empty stomach.
How Motiwin 1mg/ml Suspension works:
Motiwin 1mg/ml oral suspension is a medication that enhances gastrointestinal motility. Its mechanism involves central action on the brain's emetic center, suppressing nausea and vomiting. Additionally, it stimulates increased peristalsis in the upper gastrointestinal tract, facilitating efficient gastric emptying and food passage.
SAFETY ADVICE
KidneyCAUTION
Exercise caution when administering Motiwin 1mg/ml Suspension to individuals with advanced kidney impairment. Dosage modification of Motiwin 1mg/ml Suspension might be necessary. Physician consultation is advised. Routine assessment of kidney function, especially during extended treatment, is recommended.
LiverCAUTION
For individuals with hepatic impairment, administering Motiwin 1mg/ml Suspension requires careful consideration. Dosage modification may be necessary. Physician consultation is advised. Motiwin 1mg/ml Suspension is unsuitable for children experiencing severe liver dysfunction. Pediatric medical advice is essential prior to administration.
What if you forget to take Motiwin 1mg/ml Suspension :
If your pediatrician hasn't prescribed a different schedule, administer the missed dose upon remembering. However, omit the dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate, and adhere to the recommended dosage frequency.
Facts to Know About Motiwin 1mg/ml Suspension
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Digestive System |
| Behavioral Class | Prokinetic agent with dopamine (D2) receptor antagonism |
